Dave J. Rupiper DVM, Dipl. ABVP
East Petaluma Animal Hospital
1420-B South McDowell Blvd., Petaluma, CA 94954
Phone: (707) 765-9098 Fax: (707) 765-2984 Web: EPAH.net


Paramyxovirus


Paramyxovirus was first recognized as a disease in pigeons in 1975.1 It spread through Europe by 1983 and by 1984, was present on the east coast and in Canada. It is now present in pigeon flocks throughout the US. It is not yet present in Australia, probably due to stringent import and export laws. Paramyxovirus (PMV-1) is related to another type of Paramyxovirus known as Newcastle's Disease. Newcastle's Disease is a highly infectious viral disease of poultry and other birds but seldom is a disease of pigeons. Newcastle's Disease mainly causes upper respiratory signs, neurologic signs and death. Since the incidence of this disease in the US. is low, it will not be discussed here further.

PMV-1, however, is present in show pigeons, flying breeds and wild pigeons. We will stick to the information about this virus that is pertinent to the pigeon fancier.
Transmission- PMV-1 is transmitted by direct contact1,2,3 This may occur in crowded lofts, shipping containers or even by social contact such as territorial aggression between cocks. More importantly, transmission can occur between show cages. Indirect transmission may also take place from contaminated food and water sources. Fecal dust can become airborne and further transmit the disease between lofts and pens. Vectors such as rodents and humans can transport infected dust on fur and clothing, respectively. Last, insect vectors; pigeon flies and mosquitoes, may infect birds with PMV-1 and thus should be controlled in the loft.
Route- The route of infection is predominately through inhaled or ingested particles. Occasionally, the virus may enter through membranes around the eye. The virus leaves the pigeon's body in the feces and in the respiratory discharges.
Stability- The virus is sensitive to the usual disinfectants.1 Diluted bleach, quaternary ammoniums (Roccal), chlorhexidine (Nolvalsan), phenolics (Environ) and aldehydes (Wavicide) should be effective in disinfecting the premises.
Incubation- The incubation period (the time when first exposed to the virus until signs from disease occurs) is typically one to two weeks, may be as long as four weeks, but is not usually over six weeks. This variable time period can allow the disease to spread slowly throughout the loft. Carriers may exist that are shedding the virus in their feces but not show any signs.
Severity- Different strains exist which may cause mild to severe disease. Young, unvaccinated, unexposed pigeons are at an increased risk. If left untreated and the virus allowed to run its course, 20-80% of the flock may develop signs. Up to 90% of the birds showing neurologic signs may die.1,2 Infected pigeons will form antibodies to fight off PMV-1 within 2-3 weeks; a percentage of these birds will recover.
Diagnosis- A test on an infected bird's blood serum will confirm exposure to PMV-1. Unfortunately, this test is reliable only in unvaccinated pigeons or 8-10 months after vaccination. It tells the veterinarian that the bird tested has been exposed but gives little information on the present state of the disease. More involved tests may include isolating the virus or identifying the virus in tissues of an affected bird. These tests are performed by veterinary laboratories.
Signs- Initially, infected pigeons will consume more water and have watery, greenish droppings. They will often go off feed, act depressed, rest fluffed-up and lose weight. Later in the course of the disease, birds may develop neurologic signs. The first being incoordination and inability to fly. Head and neck twisting is easily recognized and often leads to circling or head and neck tremors. Paralysis or weakness of wings and legs can also occur. Nine out of 10 birds with prominent neurologic signs will die and unvaccinated squab mortality may reach 100%.

It is important to confirm that PMV-1 is the cause of a suspected outbreak since other diseases may manifest signs similar to PMV-1. Salmonella (Paratyphoid), Herpes (Pigeon Herpes Encephalomyelitis Virus, PHEV), Newcastle's Disease and intoxications (lead, zinc, and organophosphates) also cause neurologic signs and should be ruled-out as potential causes. Necropsies (autopsy) of dead and ill birds will provide information in determining the true cause.
Treatment- Once PMV-1 enters a loft, it may persist in the flock in asymptomatic carriers. Flying breeds with obvious neurologic signs should be culled as they may remain carriers, cannot usually be safely flown and are often unthrifty breeding birds. Show breeds can be strictly isolated from the flock and bred but may produce infected, carrier offspring. Most fanciers elect to depopulate birds with severe neurologic signs. Isolation of affected birds should be done immediately and performed on a daily basis as more affected birds are identified. Due to the long incubation period, disposal of all affected birds seldom controls the spread of the disease.

Supportive care is recommended for the lightly affected and non-affected remaining birds. Sulfa drugs such as Vetasulid (sulfachlorpyridazine) and Bactrim (sulfamethoxazole/trimethoprim) in the water are effective at controlling secondary infections. Cleaning and disinfecting watering devices, food dishes and surface areas will help control dissemination of the virus through fecal contamination. Providing warmth, good feed and fresh water will also help.

The most effective method to control the disease is to immediately vaccinate all apparently healthy birds in the face of the outbreak. Vaccinating already infected birds does little good and is not recommended. Maine Biological Laboratories' killed PMV-1 vaccine has proven to be very effective in stimulating an immune response and thus prevent disease. The vaccine does not, however, prevent infection; it merely limits the deleterious effects of the natural disease. Vaccinated birds, therefore, may carry a PMV-1 infection but not show signs.
Prevention- The pigeon fancy, through intermingling of multiple birds from multiple sources during shows and races, predisposes pigeons to contracting PMV-1 and other infectious diseases. Preventing introduction of the virus into the loft is the key to protecting your flock. Feral pigeons should be excluded, show birds should be isolated or kept in a separate loft when returning from shows, and racing birds need to be trained to enter a separate loft after flight. Preferably, this racing loft or isolation area should be across the yard but a solid barrier (preventing contact through wire or mesh) is usually effective. Do not allow potentially infected birds access to the main part of your flock.

Crowding in the loft should be dealt with as this leads to more rapid spreading of the virus and the other problems that often accompany overpopulation. All birds should be dusted with insecticide powders to eliminate the common insect vectors, pigeon flies and lice. The loft should always be kept in a clean state.

As stated already, vaccinating for PMV-1 is the best means to establish and maintain a healthy paramyxovirus protected loft. The vaccine manufacturer recommends vaccination at 4 weeks of age and a booster 4-8 weeks later. Older, unvaccinated birds are also vaccinated and boostered 4-8 weeks later and then re- vaccinated annually. Vaccinate all young birds 4 weeks prior to the start of the young bird racing and show seasons. Vaccinate all birds in the loft about 2 weeks before the breeding season.

Paramyxovirus can be a devastating disease in an unprotected, large flock. Protect your birds through understanding, good management and vaccination. The day will probably come when all pigeons flown in races or exhibited at local, state and national shows will require vaccination for PMV-1.

References

1. Tudor DC: Viral diseases. In Pigeon Health and Disease. Ames, Iowa State University Press, 1991, pp 19-53.

2. Dorrestein GM: Viral infections in racing pigeons. Proc Assoc Avian Vets, 1992, pp 244-257.

3. Schrag L: Healthy Pigeons. Hengersberg, West Germany, Shober Verlags-BmbH, 1989, pp 59-65.